Previous Page  3 / 9 Next Page
Information
Show Menu
Previous Page 3 / 9 Next Page
Page Background

Volume 8

Journal of Traditional Medicine & Clinical Naturopathy

Page 20

conference

series

.com

June 20-21, 2019 Dubai, UAE

Joint Meeting on

&

2

nd

World Congress on Traditional & Complemenatry Medicine

2

nd

International Conference on Herbal & Traditional Medicine

Traditional Med Meet 2019 &

Herbal Traditional 2019

June 20-21, 2019

Leptadenia hastata

leaf extracts reduce bodyweight gain and improve insulin sensitivity in two

animal models of obesity and insulin resistance

Aim:

Leptadenia hastata

(LH), an edible vegetable andmedicinal plant used traditionally in sub-SaharanAfrican

countries for various diseases. The potential anti-obesity and anti-diabetic effects of aqueous and methanol leaf

extracts of LH in high fat diet-induced obese mice and leptin-deficient (

ob/ob

) mice are investigated.

Methods:

C57Bl/6 female mice fed 60% High Fat Diet (HFD) and leptin-deficient (

ob/ob

) male mice (fed

chow diet) were treated for six weeks with 250

mg.kg

-1

of LH aqueous or methanol extracts. The time course of

changes in food intake, body weight, body fat, energy expenditure, blood glucose and plasma levels of insulin

and leptin (for HFD mice) were determined.

In vitro

effects of both extracts on lipolysis and lipogenesis were

also investigated.

Results:

In HFD animals, both extracts resulted in a significant reduction (p<0.05) in body weight (16.6%

and 18.7%) and food intake (10% and 11%) with a significant increase in 24 hrs. energy expenditure (53.3 and

61.4%). These effects were coupled with a significant decrease in fat mass (p<0.05) and in plasma leptin levels

(2.8 and 3.5 fold change). Both extracts also improved (p<0.05)-glucose tolerance and reduced fasted blood

glucose and plasma insulin levels. Consequently, HOMA-IR was reduced by 65% (compared to control group).

In

ob/ob

mice, the chronic treatment with methanol extract resulted in a significant reduction in cumulative

body weight gain (p<0.001), an improvement in both oral glucose and insulin tolerance tests (p<0.01 and

p<0.001, respectively) and a decrease in fasted plasma insulin by 64%.

In vitro

, the LH extracts decreased

lipogenesis in human pre-adipocytes and increased lipolysis in mouse primary adipocytes.

Conclusion:

LH would be beneficial as a dietary supplement in the treatment of obesity and insulin resistance

related to high fat diet consumption, acting via a reduction of food intake and fat mass and an elevation of

energy expenditure and improvement of insulin sensitivity.

Biography

Mohamed S Zaibi has pursued his BSc in Biochemistry and MSc in Nutrition and Human Physiology from the School of Sciences and his PhD

from Medical School (Dijon, France), where he worked on the effect of oral anti diabetic drugs on hepatic protein metabolism regulation. He

is the Associate Director at the School of Postgraduate Medicine & Allied Health and is the Head of BITM.

mohamed.zaibi@buckingham.ac.uk

Mohamed S Zaibi

The University of Buckingham, UK

Mohamed S Zaibi, J Tradit Med Clin Natur 2019, Volume 8